Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma Life Science Investing
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer's Disease Agitation Life Science Investing
BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle Transaction to Advance Ozuriftamab Vedotin into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma Life Science Investing
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-12 in Narcolepsy Supporting NDA Submission Life Science Investing
KORU Medical Systems Announces 510 Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic Life Science Investing
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 Life Science Investing
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week Life Science Investing
